Controlled-Release of Oral Dosage Forms

Das,Nandita;

Controlled-Release of Oral Dosage Forms

June 1, 2003

By Nandita G. Das, PhD

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-06-01-2003

Volume 2003 Supplement

Issue 3

The development of controlled-release formulations continues to be a big success for the pharmaceutical industry. The success of any technology relies on the ease of its manufacturing process and its reproducibility of desirable biopharmaceutical properties.

External Link - article-59302.pdf

Articles in this issue

Transdermal Drug Formulation and Process Development

Controlled-Release of Oral Dosage Forms

Studying In Vitro Skin Preparation and Drug Release to Optimize Dermatological Formulations

Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CHMP Recommends argenx Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

Patrick Lavery

April 28th 2025

Article

The company said that Vyvgart (efgartigimod alfa) is the first novel mechanism of action for CIDP treatment in more than 30 years.

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific

March 28th 2025

Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.